Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

A woman's diabetes improved after removing ovarian tumors that caused high testosterone levels.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Agarose/fucoidan hydrogels may help treat diabetes by supporting pancreatic cell growth.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

Glucocorticoids and thyroid hormones together are essential for fetal fat development.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Ginseng extracts protect brain cells and reduce damage in diabetic rats.

The glucose and NHA combination shows promise for hair regrowth.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Semaglutide may cause hair loss, but more research is needed to confirm this.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Some drugs linked to growth hormones may increase the chance of hair loss in women.

A quick method effectively detects banned substances in urine.

Excess glucocorticoids disrupt body systems, causing issues like osteoporosis and cognitive decline.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

New hair growth corticosterone levels are higher in diabetic mice, indicating long-term stress.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Semaglutide helps obese PCOS patients lose weight and improve health.

High 1-hour plasma glucose in PCOS increases risks of metabolic issues and gestational diabetes.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.